First Horizon Corporation filings document the public-company disclosures of a regional bank holding company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its 8-K reports furnish earnings releases, investor presentations, dividend-related matters, material modifications to security-holder rights and capital-structure events involving preferred stock.
Proxy materials describe board and shareholder voting matters, executive compensation, pay-versus-performance data and governance practices. Recent exchange and issuer filings also document the redemption, trading suspension and delisting process for the Series C preferred depositary shares, alongside the registration of FHN common stock and other preferred depositary share classes.
First Horizon Corp director reports no share ownership
First Horizon Corp director Michael L. Moehn filed an initial ownership report showing beneficial ownership of 0 shares of the company’s common stock as of the event date. The filing indicates the holdings are reported in direct form, confirming that, at this time, the director does not report any directly held common stock in the company.
First Horizon Corporation appointed Michael L. Moehn, age 56, to its Boards (First Horizon Corporation and First Horizon Bank) effective August 20, 2025. Mr. Moehn is Senior Executive Vice President and Chief Financial Officer of Ameren Corporation and will serve on FHN's Audit and Information Technology Committees. The filing discloses that Mr. Moehn may participate in FHN's non-employee director compensation programs and confirms the bank and its subsidiaries have ordinary-course banking relationships with executives, directors and certain large shareholders. The Board also amended the bylaws to increase its size from twelve to thirteen directors, effective immediately.
First Horizon Corporation (FHN) – Form 144 filing. An unidentified insider has filed a notice to sell up to 38,010 common shares through Fidelity Brokerage Services on or after 22 Jul 2025. The proposed sale has an estimated market value of $843,864.62, based on recent prices disclosed in the form.
The shares originate from two employee stock-option grants exercised on 22 Jul 2025 (grants dated 11 Feb 2019 and 19 Feb 2020), representing 12,475 and 25,535 shares, respectively. No other sales by the filer were reported in the past three months. With 507.2 million shares outstanding, the planned disposition equals roughly 0.0075 % of total shares—an immaterial float supply increase in absolute terms.
The signer affirms no undisclosed adverse information and acknowledges potential criminal liability for misstatements. While the dollar amount is modest relative to FHN’s market capitalization, investors often monitor Form 144s as an indicator of insider sentiment and forthcoming supply.